161 related articles for article (PubMed ID: 32578416)
1. Vanadium(V/IV)-Transferrin Binding Disrupts the Transferrin Cycle and Reduces Vanadium Uptake and Antiproliferative Activity in Human Lung Cancer Cells.
Levina A; Lay PA
Inorg Chem; 2020 Nov; 59(22):16143-16153. PubMed ID: 32578416
[TBL] [Abstract][Full Text] [Related]
2. High cytotoxicity of vanadium(IV) complexes with 1,10-phenanthroline and related ligands is due to decomposition in cell culture medium.
Le M; Rathje O; Levina A; Lay PA
J Biol Inorg Chem; 2017 Jul; 22(5):663-672. PubMed ID: 28374136
[TBL] [Abstract][Full Text] [Related]
3. Binding patterns of vanadium ions with different valence states to human serum transferrin studied by HPLC/high-resolution ICP-MS.
Nagaoka MH; Yamazaki T; Maitani T
Biochem Biophys Res Commun; 2002 Sep; 296(5):1207-14. PubMed ID: 12207902
[TBL] [Abstract][Full Text] [Related]
4. Constructing transferrin receptor targeted drug delivery system by using doxorubicin hydrochloride and vanadocene dichloride.
Zhang Y; Xiang J; Liu Y; Zhang X; Tang Y
Bioorg Med Chem Lett; 2011 Oct; 21(19):5982-6. PubMed ID: 21862329
[TBL] [Abstract][Full Text] [Related]
5. Controversial Role of Transferrin in the Transport of Ruthenium Anticancer Drugs.
Levina A; Chetcuti ARM; Lay PA
Biomolecules; 2022 Sep; 12(9):. PubMed ID: 36139158
[TBL] [Abstract][Full Text] [Related]
6. Applying the Fe(III) binding property of a chemical transferrin mimetic to Ti(IV) anticancer drug design.
Parks TB; Cruz YM; Tinoco AD
Inorg Chem; 2014 Feb; 53(3):1743-9. PubMed ID: 24422475
[TBL] [Abstract][Full Text] [Related]
7. Binding of vanadium to human serum transferrin - voltammetric and spectrometric studies.
Azevedo CG; Correia I; Dos Santos MMC; Santos MFA; Santos-Silva T; Doutch J; Fernandes L; Santos HM; Capelo JL; Pessoa JC
J Inorg Biochem; 2018 Mar; 180():211-221. PubMed ID: 29355752
[TBL] [Abstract][Full Text] [Related]
8. Development of docetaxel nanocrystals surface modified with transferrin for tumor targeting.
Choi JS; Park JS
Drug Des Devel Ther; 2017; 11():17-26. PubMed ID: 28031702
[TBL] [Abstract][Full Text] [Related]
9. Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin.
Yang Y; Zhang X; Wang X; Zhao X; Ren T; Wang F; Yu B
Int J Pharm; 2014 Jun; 467(1-2):113-22. PubMed ID: 24661944
[TBL] [Abstract][Full Text] [Related]
10. Transferrin Cycle and Clinical Roles of Citrate and Ascorbate in Improved Iron Metabolism.
Levina A; Lay PA
ACS Chem Biol; 2019 May; 14(5):893-900. PubMed ID: 30973710
[TBL] [Abstract][Full Text] [Related]
11. Interaction of vanadium(IV) with human serum apo-transferrin.
Mehtab S; Gonçalves G; Roy S; Tomaz AI; Santos-Silva T; Santos MF; Romão MJ; Jakusch T; Kiss T; Pessoa JC
J Inorg Biochem; 2013 Apr; 121():187-95. PubMed ID: 23411030
[TBL] [Abstract][Full Text] [Related]
12. Binding patterns of vanadium to transferrin in healthy human serum studied with HPLC/high resolution ICP-MS.
Nagaoka MH; Akiyama H; Maitani T
Analyst; 2004 Jan; 129(1):51-4. PubMed ID: 14737583
[TBL] [Abstract][Full Text] [Related]
13. Stabilities and Biological Activities of Vanadium Drugs: What is the Nature of the Active Species?
Levina A; Lay PA
Chem Asian J; 2017 Jul; 12(14):1692-1699. PubMed ID: 28401668
[TBL] [Abstract][Full Text] [Related]
14. Contrasting synergistic anion effects in vanadium(V) binding to nicatransferrin versus human serum transferrin.
Gaffney JP; Valentine AM
Biochemistry; 2009 Dec; 48(49):11609-11. PubMed ID: 19921860
[TBL] [Abstract][Full Text] [Related]
15. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
Lee AW; Oates PS; Trinder D
Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
[TBL] [Abstract][Full Text] [Related]
16. Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
Loza-Rosas SA; Vázquez-Salgado AM; Rivero KI; Negrón LJ; Delgado Y; Benjamín-Rivera JA; Vázquez-Maldonado AL; Parks TB; Munet-Colón C; Tinoco AD
Inorg Chem; 2017 Jul; 56(14):7788-7802. PubMed ID: 28644630
[TBL] [Abstract][Full Text] [Related]
17. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
18. Urea Gel Electrophoresis in Studies of Conformational Changes of Transferrin on Binding and Transport of Non-Ferric Metal Ions.
Levina A; Wang B; Lay PA
Gels; 2021 Dec; 8(1):. PubMed ID: 35049554
[TBL] [Abstract][Full Text] [Related]
19. Preparation of iron-deficient tissue culture medium by deferoxamine-sepharose treatment and application to the differential actions of apotransferrin and diferric transferrin.
Eby JE; Sato H; Sirbasku DA
Anal Biochem; 1992 Jun; 203(2):317-25. PubMed ID: 1416028
[TBL] [Abstract][Full Text] [Related]
20. Ti(IV) uptake and release by human serum transferrin and recognition of Ti(IV)-transferrin by cancer cells: understanding the mechanism of action of the anticancer drug titanocene dichloride.
Guo M; Sun H; McArdle HJ; Gambling L; Sadler PJ
Biochemistry; 2000 Aug; 39(33):10023-33. PubMed ID: 10955990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
